Spectra for:
Satoshi Kawatake, Kazufumi Nakamura, Masanori Inagaki, Ryuichi Higuchi
Compound 1 LMC-1-6;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3R,4E)-2-[(2R)-2-HYDROXY-DOCOSANOYLAMINO]-14-METHYL-4-HEXADECENE-1,3-DIOL
![LMC-1-6;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3R,4E)-2-[(2R)-2-HYDROXY-DOCOSANOYLAMINO]-14-METHYL-4-HEXADECENE-1,3-DIOL](/api/compound/Ff8iEDD9axC.png?h=300&w=458 "LMC-1-6;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3R,4E)-2-[(2R)-2-HYDROXY-DOCOSANOYLAMINO]-14-METHYL-4-HEXADECENE-1,3-DIOL")
Compound 2 LMC-2-1;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R)-2-[(2R)-2-HYDROXY-HEXADECANOYLAMINO]-16-METHYL-OCTADECANE-1,3,4-TRIOL
![LMC-2-1;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R)-2-[(2R)-2-HYDROXY-HEXADECANOYLAMINO]-16-METHYL-OCTADECANE-1,3,4-TRIOL](/api/compound/Ejy8N0AzPfq.png?h=300&w=458 "LMC-2-1;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R)-2-[(2R)-2-HYDROXY-HEXADECANOYLAMINO]-16-METHYL-OCTADECANE-1,3,4-TRIOL")
Compound 3 LMC-2-3;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R,9Z)-2-[(2R)-2-HYDROXY-HEXADECANOYLAMINO]-9-DOCOSENE-1,3,4-TRIOL
![LMC-2-3;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R,9Z)-2-[(2R)-2-HYDROXY-HEXADECANOYLAMINO]-9-DOCOSENE-1,3,4-TRIOL](/api/compound/6MvI4ArtrD4.png?h=300&w=458 "LMC-2-3;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R,9Z)-2-[(2R)-2-HYDROXY-HEXADECANOYLAMINO]-9-DOCOSENE-1,3,4-TRIOL")
Compound 4 LMC-2-5;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R)-2-[(2R)-2-HYDROXY-DOCOSANOYLAMINO]-HEXADECANE-1,3,4-TRIOL
![LMC-2-5;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R)-2-[(2R)-2-HYDROXY-DOCOSANOYLAMINO]-HEXADECANE-1,3,4-TRIOL](/api/compound/BO7CBWEgoEX.png?h=300&w=458 "LMC-2-5;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R)-2-[(2R)-2-HYDROXY-DOCOSANOYLAMINO]-HEXADECANE-1,3,4-TRIOL")
Compound 5 LMC-2-6;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R)-2-[(2R)-2-HYDROXY-DOCOSANOYLAMINO]-14-METHYL-HEXADECANE-1,3,4-TRIOL
![LMC-2-6;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R)-2-[(2R)-2-HYDROXY-DOCOSANOYLAMINO]-14-METHYL-HEXADECANE-1,3,4-TRIOL](/api/compound/DvnDBp2m0MJ.png?h=300&w=458 "LMC-2-6;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R)-2-[(2R)-2-HYDROXY-DOCOSANOYLAMINO]-14-METHYL-HEXADECANE-1,3,4-TRIOL")
Compound 6 LMC-2-12;LUIDIACEREBROSIDE-B;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R)-2-[(2R)-2-HYDROXYTETRACOSANOYLAMINO]-16-METHYL-OCTADECANE-1,3,4-TRIOL
![LMC-2-12;LUIDIACEREBROSIDE-B;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R)-2-[(2R)-2-HYDROXYTETRACOSANOYLAMINO]-16-METHYL-OCTADECANE-1,3,4-TRIOL](/api/compound/9ADLbqlN0SV.png?h=300&w=458 "LMC-2-12;LUIDIACEREBROSIDE-B;1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R)-2-[(2R)-2-HYDROXYTETRACOSANOYLAMINO]-16-METHYL-OCTADECANE-1,3,4-TRIOL")
Citation
| Citation | CHEM.PHARM.BULL.,50,1091(2002) |
|---|---|
| Journal | Chemical and Pharmaceutical Bulletin |
| Issue | 8 |
| Volume | 50 |
| Page(s) | 1091-1096 |
| Year | 2002 |
| Author(s) | Satoshi Kawatake, Kazufumi Nakamura, Masanori Inagaki, Ryuichi Higuchi |
| Publisher | Pharmaceutical Society of Japan |
| DOI | 10.1248/cpb.50.1091 |